Immunity to cytomegalovirus in early life
CMV is the most common congenital infection and is the leading non-genetic cause of neurological defects. CMV infection in early life is also associated with intense and prolonged viral excretion, indicating limited control of viral replication. This review summarizes our current understanding of th...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00552/full |
id |
doaj-85e97f828d4d41b4904879237dd35d47 |
---|---|
record_format |
Article |
spelling |
doaj-85e97f828d4d41b4904879237dd35d472020-11-24T20:42:18ZengFrontiers Media S.A.Frontiers in Immunology1664-32242014-10-01510.3389/fimmu.2014.00552116844Immunity to cytomegalovirus in early lifeAriane eHuygens0Nicolas eDauby1David eVermijlen2Arnaud eMarchant3Université Libre de BruxellesUniversité Libre de BruxellesUniversité Libre de BruxellesUniversité Libre de BruxellesCMV is the most common congenital infection and is the leading non-genetic cause of neurological defects. CMV infection in early life is also associated with intense and prolonged viral excretion, indicating limited control of viral replication. This review summarizes our current understanding of the innate and adaptive immune responses to CMV infection during fetal life and infancy. It illustrates the fact that studies of congenital CMV infection have provided a proof of principle that the human fetus can develop anti-viral innate and adaptive immune responses, indicating that such responses should be inducible by vaccination in early life. The review also emphasizes the fact that our understanding of the mechanisms involved in symptomatic congenital CMV infection remains limited.http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00552/fullCytomegalovirusDendritic CellsFetusNK cellsInfantB lymphocytes |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ariane eHuygens Nicolas eDauby David eVermijlen Arnaud eMarchant |
spellingShingle |
Ariane eHuygens Nicolas eDauby David eVermijlen Arnaud eMarchant Immunity to cytomegalovirus in early life Frontiers in Immunology Cytomegalovirus Dendritic Cells Fetus NK cells Infant B lymphocytes |
author_facet |
Ariane eHuygens Nicolas eDauby David eVermijlen Arnaud eMarchant |
author_sort |
Ariane eHuygens |
title |
Immunity to cytomegalovirus in early life |
title_short |
Immunity to cytomegalovirus in early life |
title_full |
Immunity to cytomegalovirus in early life |
title_fullStr |
Immunity to cytomegalovirus in early life |
title_full_unstemmed |
Immunity to cytomegalovirus in early life |
title_sort |
immunity to cytomegalovirus in early life |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2014-10-01 |
description |
CMV is the most common congenital infection and is the leading non-genetic cause of neurological defects. CMV infection in early life is also associated with intense and prolonged viral excretion, indicating limited control of viral replication. This review summarizes our current understanding of the innate and adaptive immune responses to CMV infection during fetal life and infancy. It illustrates the fact that studies of congenital CMV infection have provided a proof of principle that the human fetus can develop anti-viral innate and adaptive immune responses, indicating that such responses should be inducible by vaccination in early life. The review also emphasizes the fact that our understanding of the mechanisms involved in symptomatic congenital CMV infection remains limited. |
topic |
Cytomegalovirus Dendritic Cells Fetus NK cells Infant B lymphocytes |
url |
http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00552/full |
work_keys_str_mv |
AT arianeehuygens immunitytocytomegalovirusinearlylife AT nicolasedauby immunitytocytomegalovirusinearlylife AT davidevermijlen immunitytocytomegalovirusinearlylife AT arnaudemarchant immunitytocytomegalovirusinearlylife |
_version_ |
1716822626492481536 |